Zhejiang ALK received the "Drug Registration Certificate" for Amlodipine Besylate Tablets from the U.S

Recently, Zhejiang ALK Pharmaceuticals Co., Ltd. received the "Drug Registration Certificate" for Measartan Potassium Tablets issued by the National Medical Products Administration. The generic name of this drug is Measartan Potassium Tablets, with main ingredient Measartan Potassium, available in two specifications: 40mg and 80mg. The approval number is valid until September 29, 2030. Measartan Potassium Tablets can be used to treat primary hypertension in adults, and the company received the acceptance notice in 2024. This approval is considered equivalent to passing the consistency evaluation, which will enrich the company's product pipeline. However, due to the particularity of the pharmaceutical industry, drug sales are affected by policies, market conditions, and other factors, making the specific sales situation uncertain. The company reminds investors to pay attention to risks